FindTrial
Sign In

Low dose Anti Snake Venom for the treatment of neurotoxic snake bite

CLINICAL PROFILE AND COMPLICATIONS OF NEUROTOXIC SNAKE BITE AND COMPARISON OF TWO REGIMENS OF POLYVALENT ASV IN ITS TREATMENT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/06/005893
Enrollment
51
Registered
2015-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Snake bite victims with features of neurotoxic envenomation

Interventions

Intervention1: Anti Snake Venom Dosage according to the National ASV protocol: 100 ml ASV intravenously at admission, followed by 100 ml more at 2 hours after admission if features of neurotoxic enven

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients attending JIPMER casualty department with history of snake bite and evidence of neurotoxicity were included for the study

Exclusion criteria

Exclusion criteria: Patients with evidence of hemotoxicity

Design outcomes

Primary

MeasureTime frame
Duration of mechanical ventilationTimepoint: the number of hours mechanical ventilation was required, i.e, from the time point of intubation till the time point of extubation.—

Secondary

MeasureTime frame
time to complete resolution of ptosis, quantity of ASV used, reactions to ASV, complicationsTimepoint: time to resolution of ptosis in days, quantity of ASV in number of vials used per patient—

Countries

India

Contacts

Public ContactKrishna Sarin M S

JIPMER

tkduttajipmer@yahoo.co.uk9443602330

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026